Reading this on a mobile device? Try our optimized mobile version here:

October 19, 2012
Sign upForwardArchiveAdvertise
Right Care. Right Now.

  Critical Care Update 
  • Study: Universal treatment reduces ICU bloodstream infections
    Bloodstream infections dropped 44% when all ICU patients were bathed in antibacterial agents rather than just screened for methicillin-resistant Staphylococcus aureus, researchers from the University of California, Irvine School of Medicine, told the IDWeek 2012 conference. Researcher Dr. Susan Huang said the study prompted Hospital Corporation of America to switch to the universal treatment policy in ICUs at all of its 160 hospitals. MedPage Today (free registration) (10/18) LinkedInFacebookTwitterEmail this Story
  • Study: Chloride-restrictive fluids reduce kidney risks
    ICU patients given chloride-restrictive intravenous fluids instead of chloride-liberal fluids had lower rates of acute kidney injury and less use of renal replacement therapy, according to a study at an Australian hospital that was reported in the Journal of the American Medical Association. Dr. Jorge Guzman of the Cleveland Clinic said the data likely will cause physicians to re-evaluate how they prescribe fluids for critically ill patients. Medscape (free registration) (10/16) LinkedInFacebookTwitterEmail this Story
  • Other News
6 Lessons Learned About Hospital Smartphone Integration
As more and more hospitals work to incorporate smartphones into their communication network, they have learned important lessons that can help other facilities make a smooth transition. Read white paper.

  Medicine in the News 
  • CDC: Meningitis deaths rise to 20
    The latest death toll from the meningitis outbreak linked to tainted steroid injections rose to 20, CDC officials reported on Thursday. Laboratory tests have confirmed the presence of a fungus called Exserohilum rostratum in unopened methylprednisolone acetate vials packed by the New England Compounding Center in Framingham, Mass. Los Angeles Times/Booster Shots blog (tiered subscription model) (10/18) LinkedInFacebookTwitterEmail this Story
  • Report: Quality issues at pharma factories contribute to drug shortage
    A congressional report found that almost a third of the drug industry's manufacturing capacity for sterile injectable drugs is down due to quality issues, contributing to a shortage of critical treatments. Compounding pharmacies took on a greater role as health professionals looked for alternative sources. Drugmakers may hesitate to address problems because stopping production can be very costly, according to former plant employees and several industry observers. Drugmakers and regulators say quality remains high, and large investments are made to maintain and improve manufacturing. The New York Times (tiered subscription model) (10/17) LinkedInFacebookTwitterEmail this Story
  Trends and Technology 
  • Study: Computerized order entry can help prevent thromboembolism
    Compliance with guidelines for the prevention of venous thromboembolism increased from 66% to 84% with the use of a mandatory computerized order entry-based system, according to a study in the Archives of Surgery. Venous thromboembolic events were 36% less likely with the use of the system, the study found. The rate of deep vein thrombosis declined from a baseline of 2.3% to 0.3%, researchers said. MedPage Today (free registration) (10/15) LinkedInFacebookTwitterEmail this Story
  • Other News
Not all those who wander are lost."
--J.R.R. Tolkien,
British writer, poet, philologist and professor

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Sales Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent Critical Care SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information